Showing results (2141-2150 of 5,921) with videos related to
Sort By:
Pageof 593
Arthritis Research & Therapy|January 19, 2012
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trialDona L Fleishaker, Juan A Garcia Meijide, Andriy Petrov, et al.Arthritis Research & Therapy|December 17, 2011
Regenerative potential of human muscle stem cells in chronic inflammationBouke J Duijnisveld, Anne Bigot, Karel G M Beenakker, et al.Arthritis Research & Therapy|December 17, 2011
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjectsPaul Eggleton, Edwin Bremer, Joanna M Tarr, et al.Arthritis Research & Therapy|December 14, 2011
Effects of Wnt3A and mechanical load on cartilage chondrocyte homeostasisRhian S Thomas, Alan R Clarke, Victor C Duance, et al.Arthritis Research & Therapy|December 14, 2011
Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysisPatricia Guyot, Peter Taylor, Robin Christensen, et al.Arthritis Research & Therapy|April 18, 2012
miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4Jing Li, Jingang Huang, Liming Dai, et al.Arthritis Research & Therapy|February 10, 2012
Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritisNatalie A Carter, Elizabeth C Rosser, Claudia MauriArthritis Research & Therapy|February 9, 2012
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow upMark Houseman, Catherine Potter, Nicola Marshall, et al.Arthritis Research & Therapy|March 8, 2012
Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityFumihito Suzuki, Tetsuo Kubota, Yasunari Miyazaki, et al.Pageof 593